HIV Study on MEasuring the Reservoir on Cellular Level to CUre Infection

NCT04305665 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 25

Last updated 2024-01-31

No results posted yet for this study

Summary

The aim of this study is to gain new insights into HIV latency and reversal through extensive blood and tissues sampling (lymph node and colon biopsies) from 25 individuals under ART.

Conditions

Sponsors & Collaborators

  • University Hospital, Ghent

    lead OTHER

Principal Investigators

  • Linos Vandekerckhove, MD PhD · University Hospital, Ghent

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-24
Primary Completion
2024-12-31
Completion
2025-12-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04305665 on ClinicalTrials.gov